1.
Liang J-H, Wang L, Zhu H-Y, Qian J, Liao H, Wu J-Z, Xia Y, Wu W, Cao L, Fan L, Li J-Y, Xu W. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica 2020; 105(1):e29-e32; https://doi.org/10.3324/haematol.2019.220301.